|Day Low/High||7.84 / 8.33|
|52 Wk Low/High||6.07 / 23.97|
The Dow Jones Industrial Average declined on Thursday after securing new records for four consecutive days.
Teva's price action has been a disaster so far this year, but that could be about to change. The long-term price action suggests traders are warming to Teva's turnaround plan.
Teva options now total more than Pfizer and Merck combined.
But the stock is still undervalued, and we have our doubts about deal speculation.
The Dow reaches a new intraday record high Thursday, following Walt Disney's deal to buy Twenty-First Century Fox's film and TV businesses for $52.4 billion.
Teva Pharmaceutical Industries Ltd. (NYSE & TASE: TEVA) announced today a comprehensive restructuring plan to significantly reduce its cost base, unify and simplify its organization and improve business performance,...
Jim Cramer is bullish on Applied Materials, VMware, Kemet, Finisar.
Jim Cramer says he's optimistic this bull will stay strong, but it's always prudent to take gains and build a cash position.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will issue a press release on its restructuring plan and additional measures to improve its business and financial performance on Thursday, December...
The broadcast scored an 11.6 metered rating, tops on the night, but short of last week's total.
The Dow, S&P 500 and Nasdaq all finished higher on Monday.
Viagra has annual sales of about $1.4 billion.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the exclusive launch of its generic Viagra ®1 (sildenafil citrate) tablets in the U.
We believe the impact of Revance's announcement will be overcome, but are downgrading the stock now to allow time for the headline dust to settle.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the publication of data from the pivotal Phase III HALO study evaluating the efficacy, safety and tolerability of two subcutaneous dose regimens of...
The Israel-based drugmaker on Nov. 27 unveiled a a new organizational structure and said it plans to announce a detailed restructuring plan next month.
Teva Pharmaceutical Industries Ltd. (NYSE & TASE:TEVA) announced today a new organization and leadership structure aimed to achieve better commercial focus and drive value creation.
As consumers across the U.S. kick off the busiest shopping season of the year, Wall Street finished the week in solidly positive territory with the S&P 500 and Nasdaq both closing at record highs.
While shoppers were busy looking for bargains at the mall, traders were busy doing the same on Wall Street.
As consumers across the U.S. kick off the busiest shopping season of the year, Wall Street continues higher on Friday.
As consumers across the U.S. kick off the busiest shopping season of the year, Wall Street opens higher on Friday.
As consumers across the U.S. kick off the busiest shopping season of the year, Wall Street is indicated to open higher on Friday.
U.S. stock futures are higher on Friday, as both retailers and shoppers prepare for the frenzy that is Black Friday.
Teva Pharmaceuticals, the world's biggest generic drugmaker, could be preparing major cuts to its 6,800-strong U.S. workforce amid slumping profits and falling prices.
The troubled drug firm slashed its dividend by 75% in August, but its current dividend payout ratio and yield can tell us a lot about the future.
Can Teva, which slashed its dividend by 75% in August, maintain its current quarterly dividend?
Upcoming catalysts will redefine the biotech market -- and here are 3 names that will feel the impact.
Teva Pharmaceuticals USA, a subsidiary of Teva Pharmaceutical Industries Ltd.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.